Our generics business has grown to be among the largest in the U.S. We develop, manufacture and commercialize complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals across a broad range of therapeutic categories. Our retail and institutional portfolio contains approximately 200 product families*, many of which represent difficult-to-manufacture products or products that have a high barrier-to-entry such as oncologics, anti-infectives and supportive care to healthcare providers.
We distribute our products through deeply-held relationships with customers, who for close to 20 years have associated the Amneal name with an unwavering commitment to quality, service and value. You can find our products at pharmacies and healthcare institutions throughout the U.S. and Puerto Rico as well as in the U.K. and Germany.
Learn more about our Generic products:
*As of May 2018